Idiopathic and secondary forms of retroperitoneal fibrosis: A diagnostic approach

Revue de Medecine Interne

Volumn 36, Issue 1, 2015, Pages 15-21

  Urban, M L ^a   Palmisano, A ^a   Nicastro, M ^a   Corradi, D ^a   Buzio, C ^a   Vaglio, A ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Idiopathic retroperitoneal fibrosis; IgG4 related disease; Retroperitoneal fibrosis; Secondary retroperitoneal fibrosis

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR5; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G4; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TAMOXIFEN; TOCILIZUMAB; VEMURAFENIB; IMMUNOGLOBULIN G;

ABDOMINAL PAIN; ABDOMINAL SURGERY; AUTOIMMUNE DISEASE; BACKACHE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ENVIRONMENTAL FACTOR; ERDHEIM CHESTER DISEASE; ERYTHROCYTE SEDIMENTATION RATE; HISTIOCYTOSIS; HUMAN; HYDRONEPHROSIS; IDIOPATHIC DISEASE; IDIOPATHIC RETROPERITONEAL FIBROSIS; INCIDENCE; KIDNEY FAILURE; LABORATORY TEST; LAPAROSCOPIC SURGERY; LEG EDEMA; LOW DRUG DOSE; NEPHROSTOMY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; PROGNOSIS; PROTEIN EXPRESSION; REMISSION; RETROPERITONEAL FIBROSIS; REVIEW; SECONDARY RETROPERITONEAL FIBROSIS; SURVIVAL TIME; TREATMENT DURATION; AUTOIMMUNE DISEASES; CLASSIFICATION; CLINICAL LABORATORY TECHNIQUES; COMPLICATION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; IMMUNOLOGY; RARE DISEASES;

AUTOIMMUNE DISEASES; CLINICAL LABORATORY TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; IMMUNOGLOBULIN G; RARE DISEASES; RETROPERITONEAL FIBROSIS;

EID: 84922337428     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2014.10.008     Document Type: Short Survey

References (49)

1. Vaglio A., Salvarani C., Buzio C. Retroperitoneal fibrosis. Lancet 2006, 367:241-251.
2. Palmisano A., Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 2009, 23:339-353.
3. Pipitone N., Vaglio A., Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012, 26:439-448.
4. Takahashi H., Yamamoto M., Suzuki C., Naishiro Y., Shinomura Y., Imai K. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 2010, 9:591-594.
5. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N Engl J Med 2012, 366:539-551.
6. Khosroshahi A., Carruthers M.N., Stone J.H., Shinagare S., Sainani N., Hasserjian R.P., et al. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013, 92:82-91.
7. Uibu T., Oksa P., Auvinen A., Honkanen E., Metsärinne K., Saha H., et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 2004, 363:1422-1426.
8. van Bommel E.F., Jansen I., Hendriksz T.R., Aarnoudse A.L. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 2009, 88:193-201.
9. Miller O.F., Smith L.J., Ferrara E.X., McAleer I.M., Kaplan G.W. Presentation of idiopathic retroperitoneal fibrosis in the pediatric population. J Pediatr Surg 2003, 38:1685-1688.
10. Vaglio A., Palmisano A., Corradi D., Salvarani C., Buzio C. Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007, 33:803-817. [vi-vii].
11. Parums D.V. The spectrum of chronic periaortitis. Histopathology 1990, 16:423-431.
12. Vaglio A., Manenti L., Allegri L., Ferrozzi F., Corradi D., Buzio C. ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?. J Intern Med 2002, 251:268-271.
13. Famularo G., Palmisano A., Afeltra A., Buzzulini F., Versari A., Minisola G., et al. Retroperitoneal fibrosis associated with psoriasis: a case series. Scand J Rheumatol 2009, 38:68-69.
14. Ramshaw A.L., Roskell D.E., Parums D.V. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol 1994, 47:721-727.
15. Salvarani C., Calamia K.T., Matteson E.L., Hunder G.G., Pipitone N., Miller D.V., et al. Vasculitis of the gastrointestinal tract in chronic periaortitis. Medicine (Baltimore) 2011, 90:28-39.
16. Martorana D., Vaglio A., Greco P., Zanetti A., Moroni G., Salvarani C., et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006, 55:126-130.
17. Boiardi L., Vaglio A., Nicoli D., Farnetti E., Palmisano A., Pipitone N., et al. CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology (Oxford) 2011, 50:1025-1032.
18. Goldoni M., Bonini S., Urban M.L., Palmisano A., De Palma G., Galletti E., et al. Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med 2014, 161:181-188.
19. Tanaka S., Komori K., Okadome K., Sugimachi K., Mori R. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg 1994, 20:235-243.
20. Tang T., Boyle J.R., Dixon A.K., Varty K. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2005, 29:353-362.
21. Pfitzenmeyer P., Foucher P., Dennewald G., Chevalon B., Debieuvre D., Bensa P., et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996, 9:1013-1019.
22. Ahmad S. Methyldopa and retroperitoneal fibrosis. Am Heart J 1983, 105:1037-1038.
23. Ahmad S. Association of metoprolol and retroperitoneal fibrosis. Am Heart J 1996, 131:202-203.
24. Catanoso M.G., Spaggiari L., Magnani L., Pipitone N., Versari A., Boiardi L., et al. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 2012, 30:776-778.
25. Couderc M., Mathieu S., Dubost J.J., Soubrier M. Retroperitoneal fibrosis during etanercept therapy for rheumatoid arthritis. J Rheumatol 2013, 40:1931-1933.
26. Thomas M.H., Chisholm G.D. Retroperitoneal fibrosis associated with malignant disease. Br J Cancer 1973, 28:453-458.
27. Rosenberg S., Katz R., Pode D., Gofrit N.O., Pizov G., Hovav N. An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral renal obstruction. Can Urol Assoc J 2013, 7:E490-E494.
28. Greco P., Vaglio A., Corradi D., Cobelli R., Zompatori M., Buzio C. Tuberculosis as a trigger of retroperitoneal fibrosis. Clin Infect Dis 2005, 41:e72-e75.
29. Haroche J., Cohen-Aubart F., Arnaud L., Hervier B., Charlotte F., Drier A., et al. [Erdheim-Chester disease]. Rev Med Interne 2014, 10.1016/j.revmed.2014.04.007.
30. Corradi D., Maestri R., Palmisano A., Bosio S., Greco P., Manenti L., et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 2007, 72:742-753.
31. Vaglio A., Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 2005, 17:34-40.
32. Vaglio A., Corradi D., Manenti L., Ferretti S., Garini G., Buzio C. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003, 114:454-462.
33. Palmisano A., Corradi D., Carnevali M.L., Alberici F., Silini E.M., Gatti R., et al. Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. Clin Nephrol 2010, 74:485-490.
34. Vaglio A., Palmisano A., Ferretti S., Alberici F., Casazza I., Salvarani C., et al. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford) 2008, 47:315-318.
35. Salvarani C., Pipitone N., Versari A., Vaglio A., Serafini D., Bajocchi G., et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005, 53:298-303.
36. Bakir B., Yilmaz F., Turkay R., Ozel S., Bilgiç B., Velioglu A., et al. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology 2014, 272:438-445.
37. Pipitone N., Ghinoi A., Versari A., Vaglio A., Palmisano A., Salvarani C. Images in cardiovascular medicine. Chronic periaortitis. Circulation 2008, 118:1214-1216.
38. Pipitone N., Versari A., Vaglio A., Salvarani C. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol 2011, 29(1 Suppl 64):S72-S78.
39. Vaglio A., Versari A., Fraternali A., Ferrozzi F., Salvarani C., Buzio C. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of idiopathic retroperitoneal fibrosis. Arthritis Rheum 2005, 53:122-125.
40. Cronin C.G., Lohan D.G., Blake M.A., Roche C., McCarthy P., Murphy J.M. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol 2008, 191:423-431.
41. Mirault T., Lambert M., Puech P., Argatu D., Renaud A., Duhamel A., et al. Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients. Medicine (Baltimore) 2012, 91:242-250.
42. Benson J.R., Baum M. Tamoxifen for retroperitoneal fibrosis. Lancet 1993, 341:836.
43. Vaglio A., Palmisano A., Alberici F., Maggiore U., Ferretti S., Cobelli R., et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011, 378:338-346.
44. van Bommel E.F., Pelkmans L.G., van Damme H., Hendriksz T.R. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 2013, 24:444-450.
45. Alberici F., Palmisano A., Urban M.L., Maritati F., Oliva E., Manenti L., et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 2013, 72:1584-1586.
46. Vaglio A., Greco P., Buzio C. Tamoxifen therapy for retroperitoneal fibrosis. Ann Intern Med 2006, 144:619. [author reply -20].
47. Scheel P.J., Feeley N., Sozio S.M. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med 2011, 154:31-36.
48. Maritati F., Corradi D., Versari A., Casali M., Urban M.L., Buzio C., et al. Rituximab therapy for chronic periaortitis. Ann Rheum Dis 2012, 71:1262-1264.
49. Vaglio A., Catanoso M.G., Spaggiari L., Magnani L., Pipitone N., Macchioni P., et al. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 2013, 65:2469-2475.